Smart Pills Market Growth Drivers and Opportunities by 2031
The smart pills market size is projected to reach US$ 13.22 billion by 2031 from US$ 5.01 billion in 2023. The market is expected to register a CAGR of 12.9% during 2023–2031. Remote patient monitoring through smart pills is likely to remain a key trend in the market.
Smart Pills Market Analysis
Worldwide IBS and colon cancer incidences are growing dramatically; this is expected to serve critical growth opportunities for the smart pills market. For instance, according to the published article by the National Center for Biotechnology Information, IBS prevalence among people in Spain is approximately 10%. Furthermore, globally, IBS affects around 11% of the population. Such growing IBS and cancer cases will fuel the smart pills market.
Smart Pills Market Overview
The prevalence of chronic diseases such as cancer, neurological disease, gastrointestinal diseases, and others is leading to various growth opportunities for the smart pill manufacturers to enter the market. The rising geriatric population is also likely to increase the demand for the smart pills market. Geriatric populations are more prone to neurological conditions such as dementia and Alzheimer’s disease, which increases the use of smart pills and shows a positive impact on the market. According to arc.aarpinternational.org, Germany is one of only five “super-aged” societies worldwide. By 2034, 24 million people in Germany will be 65 years or older, which is 31% of the population.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smart Pills Market: Strategic Insights
Smart Pills Market
-
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cagr.png)
CAGR (2023 - 2031)
12.9%
-
Market Size 2023
US$ 5.01 Billion
-
Market Size 2031
US$ 13.22 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Incidence of IBD and Other Chronic Diseases
FUTURE TRENDS
- Increase in Strategic Collaborations & Partnerships On Smart Pills to Favor Market
OPPORTUNITIES
- Increasing Research For Efficient Approach To Assessing GI Motility
Key Players
- CapsoVision, Inc.
- Given Imaging, Inc.
- Check-Cap
- PENTAX Medical
- Olympus
- BodyCap
- Otsuka America Pharmaceutical, Inc.
- IntroMedic
- Jinshan Science & Technology (Group) Co., Ltd.
- RF Co., Ltd.
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Application
- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring
Disease Indication
- Gastrointestinal Diseases
- Neurological Disorders
- Cancer
- Inherited Disorders
- Other Disease Indications
End User
- Hospitals
- Clinics
- Research Institutes
- Home Healthcare
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Smart Pills Market: Strategic Insights
-
CAGR (2023 - 2031)12.9% -
Market Size 2023
US$ 5.01 Billion -
Market Size 2031
US$ 13.22 Billion
![](https://www.theinsightpartners.com/assets/images/rd_int_img/tip-logo.jpg)
Market Dynamics
- Rising Incidence of IBD and Other Chronic Diseases
- Increase in Strategic Collaborations & Partnerships On Smart Pills to Favor Market
- Increasing Research For Efficient Approach To Assessing GI Motility
Key Players
- CapsoVision, Inc.
- Given Imaging, Inc.
- Check-Cap
- PENTAX Medical
- Olympus
- BodyCap
- Otsuka America Pharmaceutical, Inc.
- IntroMedic
- Jinshan Science & Technology (Group) Co., Ltd.
- RF Co., Ltd.
Regional Overview
![](https://www.theinsightpartners.com/assets/images/rd_int_img/ig-regional.png)
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_danger.png)
- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_warning.png)
- Gastrointestinal Diseases
- Neurological Disorders
- Cancer
- Inherited Disorders
- Other Disease Indications
![](https://www.theinsightpartners.com/assets/images/rd_int_img/cust_bullet_primary.png)
- Hospitals
- Clinics
- Research Institutes
- Home Healthcare
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Smart Pills Market Drivers and Opportunities
Increase in Strategic Collaborations & Partnerships On Smart Pills to Favor Market
In April 2023, Caltech researchers partnered with researchers at the Massachusetts Institute of Technology and developed the smart-pill technology to diagnose gut disorders. The research was supported in part by the U.S.-based National Science Foundation. Furthermore, in April 2022, the AARDEX group added EtectRx’s smart pills to their MEMS adherence hardware ecosystem. This new collaboration combines etectRx’s smart pill, AARDEX Group’s MEMS Adherence Software (MEMS AS) the ID-Cap System, and to trace medication-taking behaviours. Furthermore, they provide an accurate method to measure and control adherence to solid dosage medicines.
Increasing Research For Efficient Approach To Assessing GI Motility
Existing smart pills do not offer a high spatial resolution, large field-of-view (FOV), and fully wireless operation. Therefore, researchers from NYU Abu Dhabi (NYUAD) developed a new, non-invasive system to assist diagnosis and treatment of gastrointestinal motility disorders. They have generated 3D magnetic field gradients using high-frequency electromagnetic coils that encode each spatial point with a distinct magnetic field magnitude that can track the development of smart pill through the Gastrointestinal (GI) tract. Using bluetooth the field magnitude can determine precise location and transport to a smartphone. Even for electromagnets apply GI motility, and magnetic field can be incorporated into backpacks and jackets.
Smart Pills Market Report Segmentation Analysis
Key segments that contributed to the derivation of the smart pills market analysis are application, indication, and end user.
- Based on application, the smart pills market is bifurcated into capsule endoscopy, drug delivery and patient monitoring. Capsule endoscopy is further sub-segmented into colon capsule endoscopy, small bowel video capsule endoscopy, storable capsule endoscope, controllable capsule endoscopy, and others. The capsule endoscopy segment held a larger market share in 2023.
- Based on indication, the smart pills market is divided gastrointestinal diseases, neurological disorders, cancer, inherited disorders and other disease indications. The gastrointestinal diseases segment held a larger market share in 2023.
- Based on end user, the smart pills market is divided into research institutes, hospitals and clinics, and home healthcare. The hospitals and clinics segment held a larger market share in 2023.
Smart Pills Market Share Analysis by Geography
The geographic scope of the smart pills market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market and Asia Pacific is anticipated to grow with the highest CAGR in the coming years. The growing prevalence of gastrointestinal diseases will likely demand smart pills in Australia. IBS develops in 1 in 5 Australians at some point in their lifetime. Also, every year, more than 800 cases of Ulcerative colitis (UC) are diagnosed in Australia. In addition, according to Australian Government, bowel cancer is the second most significant cancer deaths in Australia and affect 1 in 14 people. People of different ages, between 50 and 74 are at a higher risk and it mainly affects both men and women. Thus, the growing prevalence of gastrointestinal diseases will likely increase demand for smart pills in this region.
Smart Pills Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2023 | US$ 5.01 Billion |
Market Size by 2031 | US$ 13.22 Billion |
Global CAGR (2023 - 2031) | 12.9% |
Historical Data | 2021-2022 |
Forecast period | 2024-2031 |
Segments Covered |
By Application
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Smart Pills Market News and Recent Developments
The smart pills market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the smart pills market are listed below:
- HealthBeacon plc extended its platform to manage complex and critical pill regimens by launching its new HB Smart Pills Management System ("HB Smart Pills"). (Source: HealthBeacon plc, Press Release, September 2022)
- PillSafe new disruptive technology and launched smart pill bottle for prescription drugs designed to ensure safety and compliance with medication in the fight against addictive drugs. (Source: PillSafe, Press Release, January 2024)
smart pills Market Report Coverage and Deliverables
The “smart pills Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Smart pills market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Smart pills market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Smart pills market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments3
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the smart pills market
- Detailed company profiles
![Report Coverage](https://www.theinsightpartners.com/assets/rdimages/report_coverage.png)
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
![Segment Covered](https://www.theinsightpartners.com/assets/rdimages/segment_covered.png)
Segment Covered
Application, Disease Indication, and End User
![Regional Scope](https://www.theinsightpartners.com/assets/rdimages/regional_scope.png)
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
![Country Scope](https://www.theinsightpartners.com/assets/rdimages/country_scope.png)
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
North America has dominated the smart pills market.
Factors such as rising demand for minimally invasive surgical procedures and increase in strategic collaborations and partnerships will boost the market.
Remote patient monitoring through smart pills is likely to remain a key trend in the market.
The smart pills market size is projected to reach US$ 13.22 billion by 2031.
The market is expected to register a CAGR of 12.9% during 2023–2031.